Effects of urocortin on spine?

Summary Introduction Urocortin (UCN) is a member of the cortico tropin-releasing factor family. UCN enhances osteoblast differentiation and inhibits osteoclasts in vitro. In the present study, the effect of UCN on spine was assessed in the rat osteopenia model. Material and methods Sprague Dawley rats (3 month old) were either ovariectomized (OVX, n = 48) or sham operated (n = 12). After 9 weeks, OVX rats were divided into 4 groups (n = 12): OVX, UCN low (3 µ/kg BW), UCN high (30 µ/kg BW), estradiol-17β-benzoate (0.2 mg/kg BW). UCN was administered daily s. c., estrogen was supplied with food for 35 d. Thereafter, the lumbar vertebral bodies were analyzed by biomechanical test, micro-CT, pQCT, gene expression and ashing analyses. Serum alkaline phosphatase (AP), beta-Crosslaps, calcium, leptin levels were assessed. Results Stiffness, BMD, BV/TV, trabecular parameters improved in UCN high group. UCN low dose had less effect on spine. AP was enhanced in UCN high group, leptin increased in both UCN groups, other serum parameters and expression of bone genes did not change. UCN high dose showed osteoprotective effect in spine. Discussion Further studies are needed to understand mechanism of UCN action on bone and to reveal potential side effects.

[1]  S. Sehmisch,et al.  Effect of Urocortin on strength and microarchitecture of osteopenic rat femur , 2015, Journal of Bone and Mineral Metabolism.

[2]  Andreas Stengel,et al.  CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress , 2014, Front. Neurosci..

[3]  R. Knight,et al.  Targeting Urocortin Signaling Pathways to Enhance Cardioprotection: Is It Time to Move from Bench to Bedside? , 2013, Cardiovascular Drugs and Therapy.

[4]  S. Sehmisch,et al.  Efficiency of 48h vs. 24h Injection of Parathyroid Hormone forAmelioration of Osteopenic Spine Properties in Male Rats , 2012 .

[5]  G. Pirianov,et al.  Urocortin is a novel regulator of osteoclast differentiation and function through inhibition of a canonical transient receptor potential 1-like cation channel. , 2012, The Journal of endocrinology.

[6]  T. Rachner,et al.  Osteoporosis: now and the future , 2011, The Lancet.

[7]  Juejin Wang,et al.  Corticotropin-releasing factor family and its receptors: pro-inflammatory or anti-inflammatory targets in the periphery? , 2011, Inflammation Research.

[8]  M. C. H. Meulen,et al.  Whole Bone Mechanics and Bone Quality , 2011, Clinical orthopaedics and related research.

[9]  Stephan Sehmisch,et al.  Effect of human parathyroid hormone hPTH (1-34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. , 2010, Bone.

[10]  P. Magni,et al.  Molecular aspects of adipokine-bone interactions. , 2010, Current molecular medicine.

[11]  Ralph Müller,et al.  Guidelines for assessment of bone microstructure in rodents using micro–computed tomography , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  K. Dresing,et al.  Differentiation dependent expression of urocortin’s mRNA and peptide in human osteoprogenitor cells: influence of BMP-2, TGF-beta-1 and dexamethasone , 2009, Journal of Molecular Histology.

[13]  Lu Xingguo,et al.  Ovariectomy‐associated changes in bone mineral density and bone marrow haematopoiesis in rats , 2009, International journal of experimental pathology.

[14]  S. Sehmisch,et al.  Short-Term Effects of Parathyroid Hormone on Rat Lumbar Vertebrae , 2009, Spine.

[15]  M. Wicke,et al.  Effect of daidzein, 4-methylbenzylidene camphor or estrogen on gastrocnemius muscle of osteoporotic rats undergoing tibia healing period. , 2009, The Journal of endocrinology.

[16]  P. Townsend,et al.  The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family. , 2009, Biochemical pharmacology.

[17]  G. Telegdy,et al.  Antidepressant-like effects of the CRF family peptides, urocortin 1, urocortin 2 and urocortin 3 in a modified forced swimming test in mice , 2008, Brain Research Bulletin.

[18]  Ľ. Stárka,et al.  The effect of leptin on bone: an evolving concept of action. , 2008, Physiological research.

[19]  I. Reid.  Relationships between fat and bone , 2008, Osteoporosis International.

[20]  U. Stöckle,et al.  [Proximal femoral fractures in the elderly. Analysis of data from health insurance providers on more than 23 million insured persons--part 1]. , 2007, Der Unfallchirurg.

[21]  E. Zorrilla,et al.  Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: Ancient CRF paralogs , 2007, Frontiers in Neuroendocrinology.

[22]  Mario Delgado,et al.  Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells. , 2007, Arthritis and rheumatism.

[23]  C. Frampton,et al.  Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responses. , 2007, Journal of the American College of Cardiology.

[24]  T. Wronski,et al.  Skeletal alterations in ovariectomized rats , 1985, Calcified Tissue International.

[25]  K. Frosch,et al.  Standardized Bending and Breaking Test for the Normal and Osteoporotic Metaphyseal Tibias of the Rat: Effect of Estradiol, Testosterone, and Raloxifene , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  D. Dempster,et al.  New Concepts in Bone Remodeling , 2006 .

[27]  D. Dempster,et al.  CHAPTER 22 – New Concepts in Bone Remodeling , 2006 .

[28]  T. Thomas.  The complex effects of leptin on bone metabolism through multiple pathways. , 2004, Current opinion in pharmacology.

[29]  Yusu Gu,et al.  The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  K. Ohama,et al.  [Estrogen and bone metabolism]. , 2003, Clinical calcium.

[31]  R. Hauger,et al.  Mediation of Corticotropin Releasing Factor Type 1 Receptor Phosphorylation and Desensitization by Protein Kinase C: A Possible Role in Stress Adaptation , 2003, Journal of Pharmacology and Experimental Therapeutics.

[32]  M. Hüfner,et al.  Cytokines, Osteoprotegerin, and RANKL In Vitro and Histomorphometric Indices of Bone Turnover in Patients With Different Bone Diseases , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  R. Knight,et al.  Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death. , 2002, Journal of molecular and cellular cardiology.

[34]  G. Nicholson,et al.  Leptin Inhibits Osteoclast Generation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  A. Levine,et al.  Urocortin in the hypothalamic PVN increases leptin and affects uncoupling proteins-1 and -3 in rats. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[36]  G. Chrousos,et al.  Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity. , 2001, The Journal of clinical endocrinology and metabolism.

[37]  V. A. Filov,et al.  Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs. , 2001, Anticancer research.

[38]  B. Riggs,et al.  The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. , 1999, Molecular endocrinology.

[39]  David Lovejoy,et al.  Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor , 1995, Nature.

[40]  D. Thompson,et al.  FDA Guidelines and animal models for osteoporosis. , 1995, Bone.

[41]  D. Kalu.  The ovariectomized rat model of postmenopausal bone loss. , 1991, Bone and mineral.

[42]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  R T Turner,et al.  The effects of ovariectomy and 17β‐estradiol on cortical bone histomorphometry in growing rats , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .